Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

New antitumor compound QM16-A described in patent literature

Nov. 21, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Idec begins phase I/II trial for 9-AC

Nov. 19, 1997

Banyu describes protein farnesyltransferase inhibitors

Nov. 19, 1997

Kyowa Hakko's UCT-1072M1, a new antitumor antibiotic

Nov. 19, 1997

Sch-207278: new protein farnesyltransferase inhibitor of microbial origin

Nov. 19, 1997

Scripps prepares MCBI analogues of antitumor antibiotics

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...